ストックスクリーナーアプリを入手
1.85
1.09%
0.02
前日終値:
$1.83
開ける：
$1.83
24時間の取引高:
626.68K
Relative Volume:
0.79
時価総額：
$117.88M
収益：
$198.53M
当期純損益:
$-63.68M
株価収益率:
-1.8098
EPS:
-1.0222
ネットキャッシュフロー:
$-41.50M
1週間 パフォーマンス:
-8.42%
1か月 パフォーマンス:
-29.92%
6か月 パフォーマンス:
-73.72%
1年 パフォーマンス:
-81.92%
1日の値動き範囲:
$1.82
$1.9288
1週間の範囲:
$1.81
$2.045
52週間の値動き範囲:
$1.81
$10.30
Treace Medical Concepts Inc Stock (TMCI) Company Profile
名前
Treace Medical Concepts Inc
セクター
電話
(904) 373-5940
住所
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
1.85 | 116.60M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-07 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-11-07 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2025-02-04 | アップグレード | BTIG Research | Neutral → Buy |
| 2024-12-31 | 開始されました | Lake Street | Buy |
| 2024-12-17 | 再開されました | JP Morgan | Neutral |
| 2024-05-16 | ダウングレード | UBS | Buy → Neutral |
| 2024-05-08 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-05-08 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-05-08 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | ダウングレード | Stifel | Buy → Hold |
| 2024-05-08 | ダウングレード | Truist | Buy → Hold |
| 2023-09-29 | 開始されました | UBS | Buy |
| 2023-05-01 | 開始されました | Truist | Buy |
| 2023-04-11 | 開始されました | Stephens | Equal-Weight |
| 2022-05-12 | 開始されました | BTIG Research | Buy |
| 2022-01-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | 開始されました | JP Morgan | Overweight |
| 2021-05-18 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-05-18 | 開始されました | SVB Leerink | Outperform |
| 2021-05-18 | 開始されました | Stifel | Buy |
すべてを表示
Treace Medical Concepts Inc (TMCI) 最新ニュース
Treace Medical Concepts (TMCI) to Release Quarterly Earnings on Thursday - Defense World
What Catalysts Are Shifting The Narrative For Treace Medical Concepts (TMCI)? - Yahoo Finance
Retail Trends: How much upside does Treace Medical Concepts Inc have2025 Major Catalysts & Weekly Top Gainers Trade List - baoquankhu1.vn
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Rating of "Reduce" by Brokerages - MarketBeat
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts (NASDAQ:TMCI) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Rating Lowered to “Sell” at Wall Street Zen - Defense World
Treace Medical Concepts to Release Q4 and Full Year 2025 Financial Results - Intellectia AI
Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Navigating a Potential 121% Upside in the Healthcare Sector - DirectorsTalk Interviews
Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026 - Bitget
Treace Medical Concepts to Release Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 - Quiver Quantitative
Why is Treace Medical Concepts Inc stock going up2025 Retail Activity & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Stockholders to Connect - ACCESS Newswire
Stifel Revises Treace Medical Concepts, Inc. (TMCI) Price Target in Sector-Wide Update - Finviz
Stifel revises Treace Medical Concepts, Inc. (TMCI) price target in sector-wide update - MSN
11 High Growth Micro-cap Stocks to Buy - Insider Monkey
Treace Medical Concepts (NASDAQ:TMCI) Upgraded at Wall Street Zen - MarketBeat
Johnson Fistel, PLLP Investigates Claims on Behalf of - GlobeNewswire
Institutional owners may consider drastic measures as Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) recent US$29m drop adds to long-term losses - simplywall.st
301,100 Shares in Treace Medical Concepts, Inc. $TMCI Acquired by Acuitas Investments LLC - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Connect - accessnewswire.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Reach Out - ACCESS Newswire
Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring A Potential 81% Upside - DirectorsTalk Interviews
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Rating of "Reduce" from Brokerages - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Treace Medical Concepts sees revenue fall in the fourth quarter - Jacksonville Daily Record
How New Analyst Targets Are Reframing The Treace Medical Concepts (TMCI) Investment Story - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts Reports Q3 2025 Financial Results - MSN
Critical Analysis: Treace Medical Concepts (NASDAQ:TMCI) versus Adagio Medical (NASDAQ:ADGM) - Defense World
Treace Medical Concepts, Inc. (TMCI): Investor Outlook Highlights 83.77% Potential Upside - DirectorsTalk Interviews
Downgrade Watch: Will Treace Medical Concepts Inc stock hit new highs in YEARJuly 2025 Highlights & Detailed Earnings Play Alerts - baoquankhu1.vn
Treace Medical Concepts’ preliminary revenue down 9% in Q4 2025 - Medical Buyer
Treace Medical CEO to Present at J.P. Morgan Healthcare Conference on January 14, 2026 - Intellectia AI
Treace Medical Issues Preliminary Q4 Results, Highlights Growth - TipRanks
Treace Medical Concepts, Inc. Provides Preliminary Revenue for the Fourth Quarter of 2025 - marketscreener.com
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue - The Manila Times
Treace Medical Concepts Reports Preliminary 2025 Revenue Results and Updates on Surgeon Adoption Trends - Quiver Quantitative
Published on: 2026-01-13 05:27:40 - ulpravda.ru
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Investors to Inquire about Securities Investigation - ACCESS Newswire
How Treace Medical Concepts Inc. stock compares to industry benchmarksAnalyst Downgrade & Advanced Technical Analysis Signals - ulpravda.ru
Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology - The Manila Times
Will Treace Medical Concepts Inc. stock recover faster than market2025 Valuation Update & Growth Oriented Trade Recommendations - Улправда
Will Treace Medical Concepts Inc. stock return to pre crisis levels2025 Pullback Review & AI Optimized Trading Strategy Guides - ulpravda.ru
Will Treace Medical Concepts Inc. stock outperform Nasdaq indexDollar Strength & High Accuracy Swing Entry Alerts - Улправда
Dow Theory LettersTreace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology - FinancialContent
Is Treace Medical Concepts Inc. stock oversold or undervaluedMarket Activity Report & Accurate Intraday Trade Tips - Улправда
How Treace Medical Concepts Inc. stock reacts to Fed rate cutsJuly 2025 Spike Watch & Precise Buy Zone Identification - Улправда
How Treace Medical Concepts Inc. stock benefits from tech adoptionJuly 2025 Update & Breakout Confirmation Alerts - Улправда
The Analyst Verdict: Treace Medical Concepts In The Eyes Of 6 Experts - Benzinga
Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Low P/S - simplywall.st
Treace Medical Concepts Inc (TMCI) 財務データ
収益
当期純利益
現金流量
EPS
1.13%
大文字化:
|
ボリューム (24 時間):